loadpatents
name:-0.12204599380493
name:-0.075410127639771
name:-0.056125164031982
KORMAN; Alan J. Patent Filings

KORMAN; Alan J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KORMAN; Alan J..The latest application filed is for "antibodies against mica and/or micb and uses thereof".

Company Profile
52.76.112
  • KORMAN; Alan J. - Piedmont CA
  • Korman; Alan J. - Piedmong CA
  • KORMAN; Alan J. - Redwood City CA
  • Korman; Alan J. - Milpitas CA
  • Korman; Alan J. - Boulder CO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies Against Mica And/or Micb And Uses Thereof
App 20220281980 - KUHNE; Michelle Renee ;   et al.
2022-09-08
Anti-GITR antibodies for cancer diagnostics
Grant 11,408,889 - Wang , et al. August 9, 2
2022-08-09
Antibodies binding to ILT4
Grant 11,401,328 - Schebye , et al. August 2, 2
2022-08-02
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof
App 20220204612 - THUDIUM; Kent B. ;   et al.
2022-06-30
Anti-nkg2a Antibodies And Uses Thereof
App 20220204618 - Bezman; Natalie ;   et al.
2022-06-30
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof
App 20220195040 - THUDIUM; Kent B. ;   et al.
2022-06-23
Anti-nkg2a Antibodies And Uses Thereof
App 20220195042 - Bezman; Natalie ;   et al.
2022-06-23
Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors
App 20220185892 - KORMAN; Alan J. ;   et al.
2022-06-16
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20220175921 - WANG; Changyu ;   et al.
2022-06-09
Antibodies against CD73 and uses thereof
Grant 11,352,440 - Lonberg , et al. June 7, 2
2022-06-07
Use Of Anti-ctla-4 Antibodies With Enhanced Adcc To Enhance Immune Response To A Vaccine
App 20220127363 - LOFFREDO; John T. ;   et al.
2022-04-28
Human monoclonal antibodies that bind CXCR4 and uses thereof
Grant 11,312,777 - Kuhne , et al. April 26, 2
2022-04-26
Antibodies Against Tim3 And Uses Thereof
App 20220089720 - SCHEBYE; Xiao Min ;   et al.
2022-03-24
Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies
Grant 11,274,150 - Bezman , et al. March 15, 2
2022-03-15
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
Grant 11,274,152 - Korman , et al. March 15, 2
2022-03-15
Antibodies Binding to Vista at Acidic pH
App 20220073617 - Johnston; Robert J. ;   et al.
2022-03-10
Antibodies against MICA and/or MICB and uses thereof
Grant 11,242,393 - Kuhne , et al. February 8, 2
2022-02-08
Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof
Grant 11,236,165 - Thudium , et al. February 1, 2
2022-02-01
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
Grant 11,236,163 - Thudium , et al. February 1, 2
2022-02-01
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
Grant 11,236,164 - Thudium , et al. February 1, 2
2022-02-01
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)
Grant 11,213,586 - Wang , et al. January 4, 2
2022-01-04
Anti-ICOS agonist antibodies and uses thereof
Grant 11,207,391 - Engelhardt , et al. December 28, 2
2021-12-28
Methods Of Treating Cancer With Antibodies Against Tim3
App 20210363242 - SCHEBYE; Xiao Min ;   et al.
2021-11-25
Compositions Comprising A Combination Of An Anti-lag-3 Antibody, A Pd-1 Pathway Inhibitor, And An Immunotherapeutic Agent
App 20210340250 - KORMAN; Alan J. ;   et al.
2021-11-04
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof
App 20210261662 - THUDIUM; Kent B. ;   et al.
2021-08-26
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof
App 20210261660 - THUDIUM; Kent B. ;   et al.
2021-08-26
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof
App 20210261661 - THUDIUM; Kent B. ;   et al.
2021-08-26
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
Grant 11,084,881 - Wang , et al. August 10, 2
2021-08-10
Anti-cd27 Antibodies And Uses Thereof
App 20210155703 - Lu; Li-Sheng ;   et al.
2021-05-27
Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereof
Grant 11,001,630 - Thudium , et al. May 11, 2
2021-05-11
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
Grant 10,988,535 - Thudium , et al. April 27, 2
2021-04-27
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
Grant 10,988,536 - Thudium , et al. April 27, 2
2021-04-27
CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy
Grant 10,983,128 - Bahjat , et al. April 20, 2
2021-04-20
Anti-ICOS agonist antibodies and uses thereof
Grant 10,898,556 - Engelhardt , et al. January 26, 2
2021-01-26
Antibodies Binding to Vista at Acidic pH
App 20210017283 - Johnston; Robert J. ;   et al.
2021-01-21
Anti-gitr Antibodies For Cancer Diagnostics
App 20210011022 - WANG; Xi-Tao ;   et al.
2021-01-14
Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors
App 20210009692 - KORMAN; Alan J. ;   et al.
2021-01-14
Antibodies Against Ox-40 And Uses Thereof
App 20200399385 - CAI; Zhehong ;   et al.
2020-12-24
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof
App 20200385466 - THUDIUM; Kent B. ;   et al.
2020-12-10
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof
App 20200385467 - THUDIUM; Kent B. ;   et al.
2020-12-10
Antibodies Comprising Modified Heavy Constant Regions
App 20200299400 - LONBERG; Nils ;   et al.
2020-09-24
Antibodies Comprising Modified Heavy Constant Regions
App 20200268901 - LONBERG; Nils ;   et al.
2020-08-27
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3), And Uses Thereof
App 20200231671 - THUDIUM; Kent B. ;   et al.
2020-07-23
Enhancing Anti-cancer Activity Of Immunomodulatory Fc Fusion Proteins
App 20200207816 - ENGELHARDT; John J. ;   et al.
2020-07-02
Anti-nkg2a Antibodies And Uses Thereof
App 20200199226 - Bezman; Natalie ;   et al.
2020-06-25
Anti-GITR antibodies for cancer diagnostics
Grant 10,690,674 - Wang , et al.
2020-06-23
Antibodies Against Tim3 And Uses Thereof
App 20200190186 - SCHEBYE; Xiao Min ;   et al.
2020-06-18
Antibodies against OX40 and uses thereof
Grant 10,683,357 - Cai , et al.
2020-06-16
Antibodies comprising modified heavy constant regions
Grant 10,653,791 - Lonberg , et al.
2020-05-19
Monoclonal Antibodies to Programmed Death 1 (PD-1)
App 20200138945 - Korman; Alan J. ;   et al.
2020-05-07
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20200115463 - WANG; Changyu ;   et al.
2020-04-16
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20200079865 - WANG; Changyu ;   et al.
2020-03-12
Antibodies Binding to ILT4
App 20200079848 - Schebye; Xiao Min ;   et al.
2020-03-12
Combination Of Anti-lag-3 Antibodies And Anti-pd-1 Antibodies To Treat Tumors
App 20200062845 - Korman; Alan J. ;   et al.
2020-02-27
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1)
App 20200062848 - KORMAN; Alan J. ;   et al.
2020-02-27
Antibodies Binding to VISTA at Acidic pH
App 20200055936 - Johnston; Robert J. ;   et al.
2020-02-20
Anti-icos Agonist Antibodies And Uses Thereof
App 20200030425 - ENGELHARDT; John J. ;   et al.
2020-01-30
Antibodies against TIM3 and uses thereof
Grant 10,533,052 - Schebye , et al. Ja
2020-01-14
Use Of Anti-ctla-4 Antibodies With Enhanced Adcc To Enhance Immune Response To A Vaccine
App 20190382490 - LOFFREDO; John T. ;   et al.
2019-12-19
Treatment Of Cancer Using A Combination Of An Anti-pd-1 Antibody And Anti-cd137
App 20190382491 - Jure-Kunkel; Maria ;   et al.
2019-12-19
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
Grant 10,501,550 - Wang , et al. Dec
2019-12-10
Anti-ICOS agonist antibodies and uses thereof
Grant 10,493,140 - Engelhardt , et al. De
2019-12-03
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
Grant 10,465,010 - Wang , et al. No
2019-11-05
Antibodies Against Mica And/or Micb And Uses Thereof
App 20190315870 - KUHNE; Michelle Renee ;   et al.
2019-10-17
Monoclonal antibodies to programmed death 1 (PD-1)
Grant 10,441,655 - Korman , et al. Oc
2019-10-15
Anti-icos Agonist Antibodies And Uses Thereof
App 20190298816 - ENGELHARDT; John J. ;   et al.
2019-10-03
Combination Therapy With Anti-cd73 Antibodies
App 20190284293 - LONBERG; Nils ;   et al.
2019-09-19
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3), And Uses Thereof
App 20190276538 - Thudium; Kent B. ;   et al.
2019-09-12
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3), And Uses Thereof
App 20190276539 - Thudium; Kent B. ;   et al.
2019-09-12
Antibodies Against Tim3 And Uses Thereof
App 20190248893 - SCHEBYE; Xiao Min ;   et al.
2019-08-15
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
Grant 10,344,089 - Thudium , et al. July 9, 2
2019-07-09
Anti-icos Agonist Antibodies And Uses Thereof
App 20190175705 - Engelhardt; John J. ;   et al.
2019-06-13
Human Ctla-4 Antibodies And Their Uses
App 20190119384 - Korman; Alan J. ;   et al.
2019-04-25
Fully Human Antibodies To Btla
App 20190119381 - MATARAZA; Jennifer Marie ;   et al.
2019-04-25
Anti-ICOS agonist antibodies and uses thereof
Grant 10,251,945 - Engelhardt , et al.
2019-04-09
Anti-icos Agonist Antibodies And Uses Thereof
App 20190076515 - Engelhardt; John J. ;   et al.
2019-03-14
Antibodies Against Cd73 And Uses Thereof
App 20190062456 - Lonberg; Nils ;   et al.
2019-02-28
Antibodies Against Cd73 And Uses Thereof
App 20190055320 - LONBERG; Nils ;   et al.
2019-02-21
Ipilimumab variant with enhanced ADCC
Grant 10,196,445 - Engelhardt , et al. Fe
2019-02-05
Human Monoclonal Antibodies That Bind Cxcr4 And Uses Thereof
App 20190031763 - KUHNE; MICHELLE R. ;   et al.
2019-01-31
Antibodies against CD73
Grant 10,167,343 - Lonberg , et al. J
2019-01-01
Fully human antibodies to BTLA
Grant 10,155,813 - Mataraza , et al. Dec
2018-12-18
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20180339042 - WANG; Changyu ;   et al.
2018-11-29
Antibodies Comprising Modified Heavy Constant Regions
App 20180333502 - LONBERG; Nils ;   et al.
2018-11-22
Enhancing Anti-cancer Activity Of Immunomodulatory Fc Fusion Proteins
App 20180312553 - ENGELHARDT; John J. ;   et al.
2018-11-01
Antibodies Against Tim3 And Uses Thereof
App 20180298097 - Schebye; Xiao Min ;   et al.
2018-10-18
Antibodies against CD73 and uses thereof
Grant 10,100,129 - Lonberg , et al. October 16, 2
2018-10-16
Anti-icos Agonist Antibodies And Uses Thereof
App 20180289790 - ENGELHARDT; John J. ;   et al.
2018-10-11
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
Grant 10,081,681 - Korman , et al. September 25, 2
2018-09-25
Antibodies against TIM3 and uses thereof
Grant 10,077,306 - Schebye , et al. September 18, 2
2018-09-18
Cxcl11 And Smica As Predictive Biomarkers For Efficacy Of Anti-ctla4 Immunotherapy
App 20180246113 - BAHJAT; Keith Sadoon ;   et al.
2018-08-30
Antibodies Against Ox40 And Uses Thereof
App 20180237534 - CAI; Zhehong ;   et al.
2018-08-23
Anti-gitr Antibodies For Cancer Diagnostics
App 20180164321 - WANG; Xi-Tao ;   et al.
2018-06-14
Human monoclonal antibodies to O8E
Grant 9,988,453 - Korman , et al. June 5, 2
2018-06-05
Antibodies Against Cd73 And Uses Thereof
App 20180127513 - LONBERG; Nils ;   et al.
2018-05-10
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3), And Uses Thereof
App 20180066054 - THUDIUM; Kent B. ;   et al.
2018-03-08
Antibodies Against Tim3 And Uses Thereof
App 20180016336 - SCHEBYE; Xiao Min ;   et al.
2018-01-18
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20180002432 - WANG; Changyu ;   et al.
2018-01-04
Antibodies Against Ox40 And Uses Thereof
App 20170306035 - CAI; Zhehong ;   et al.
2017-10-26
Antibodies Against Cd73
App 20170253665 - LONBERG; Nils ;   et al.
2017-09-07
Treatment Of Cancer Using A Combination Of An Anti-pd-1 Antibody And An Anti-cd137 Antibody
App 20170247455 - JURE-KUNKEL; Maria ;   et al.
2017-08-31
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
Grant 9,745,379 - Wang , et al. August 29, 2
2017-08-29
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1)
App 20170158767 - KORMAN; Alan J. ;   et al.
2017-06-08
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20170145104 - WANG; Changyu ;   et al.
2017-05-25
Antibodies against OX40 and uses thereof
Grant 9,644,032 - Cai , et al. May 9, 2
2017-05-09
Monoclonal Antibodies to Programmed Death 1 (PD-1)
App 20170088615 - KORMAN; Alan J. ;   et al.
2017-03-30
Antibodies against CD73
Grant 9,605,080 - Lonberg , et al. March 28, 2
2017-03-28
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
Grant 9,580,505 - Korman , et al. February 28, 2
2017-02-28
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
Grant 9,580,507 - Korman , et al. February 28, 2
2017-02-28
Human Monoclonal Antibodies to Programmed Death Ligand 1 (PD-L1)
App 20160362495 - KORMAN; Alan J. ;   et al.
2016-12-15
Antibodies Against Ox40 And Uses Thereof
App 20160347849 - CAI; Zhehong ;   et al.
2016-12-01
Methods for treating cancer using anti-PD-1 antibodies
Grant 9,492,540 - Korman , et al. November 15, 2
2016-11-15
Monoclonal antibodies to Programmed Death 1 (PD-1)
Grant 9,492,539 - Korman , et al. November 15, 2
2016-11-15
Human Ctla-4 Antibodies And Their Uses
App 20160257753 - Korman; Alan J. ;   et al.
2016-09-08
Combination Of Anti-lag-3 Antibodies And Anti-pd-1 Antibodies To Treat Tumors
App 20160222116 - KORMAN; Alan J. ;   et al.
2016-08-04
Fully Human Antibodies To Btla
App 20160222114 - MATARAZA; Jennifer Marie ;   et al.
2016-08-04
Monoclonal antibodies to programmed death 1 (PD-1)
Grant 9,387,247 - Korman , et al. July 12, 2
2016-07-12
Human Monoclonal Antibodies To O8e
App 20160168249 - Korman; Alan J. ;   et al.
2016-06-16
Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies
Grant 9,358,289 - Korman , et al. June 7, 2
2016-06-07
Antibodies Against Cd73 And Uses Thereof
App 20160145350 - Lonberg; Nils ;   et al.
2016-05-26
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20160145342 - WANG; Changyu ;   et al.
2016-05-26
Fully human antibodies to BTLA
Grant 9,346,882 - Mataraza , et al. May 24, 2
2016-05-24
Human monoclonal antibodies to O8E
Grant 9,296,822 - Korman , et al. March 29, 2
2016-03-29
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1)
App 20160075782 - Korman; Alan J. ;   et al.
2016-03-17
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
Grant 9,273,135 - Korman , et al. March 1, 2
2016-03-01
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
Grant 9,228,016 - Wang , et al. January 5, 2
2016-01-05
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20150353637 - WANG; Changyu ;   et al.
2015-12-10
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1)
App 20150337038 - KORMAN; Alan J. ;   et al.
2015-11-26
Enhancing Anti-cancer Activity Of Immunomodulatory Fc Fusion Proteins
App 20150322119 - ENGELHARDT; John J. ;   et al.
2015-11-12
Pd-1 Antibodies In Combination With A Cytokine-secreting Cell And Methods Of Use Thereof
App 20150265705 - LI; Betty ;   et al.
2015-09-24
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
Grant 9,102,725 - Korman , et al. August 11, 2
2015-08-11
Methods for treating cancer using anti-PD-1 antibodies
Grant 9,084,776 - Korman , et al. July 21, 2
2015-07-21
Methods For Treating Cancer Using Anti-pd-1 Antibodies
App 20150165025 - KORMAN; Alan J. ;   et al.
2015-06-18
Monoclonal Antibodies To Programmed Death 1 (pd-1)
App 20140348743 - Korman; Alan J. ;   et al.
2014-11-27
Methods For Treating Cancer Using Anti-pd-1 Antibodies
App 20140328833 - Korman; Alan J. ;   et al.
2014-11-06
Monoclonal Antibodies To Programmed Death 1 (pd-1)
App 20140294852 - Korman; Alan J. ;   et al.
2014-10-02
Pd-1 Antibodies In Combination With A Cytokine-secreting Cell And Methods Of Use Thereof
App 20140271684 - LI; Betty ;   et al.
2014-09-18
Human Ctla-4 Antibodies And Their Uses
App 20140234331 - Korman; Alan J. ;   et al.
2014-08-21
Methods For Treating Cancer Using Anti-pd-1 Antibodies In Combination With Anti-ctla-4 Antibodies
App 20140212422 - Korman; Alan J. ;   et al.
2014-07-31
Human CTLA-4 antibodies and their uses
Grant 8,784,815 - Korman , et al. July 22, 2
2014-07-22
Monoclonal antibodies to programmed death 1 (PD-1)
Grant 8,779,105 - Korman , et al. July 15, 2
2014-07-15
Human Monoclonal Antibodies To O8e
App 20140134180 - KORMAN; ALAN J. ;   et al.
2014-05-15
Fully Human Antibodies To Btla
App 20140017255 - MATARAZA; Jennifer Marie ;   et al.
2014-01-16
Human monoclonal antibodies to O8E
Grant 8,609,816 - Korman , et al. December 17, 2
2013-12-17
PS-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
Grant 8,580,247 - Li , et al. November 12, 2
2013-11-12
Fully human antibodies to BTLA
Grant 8,563,694 - Mataraza , et al. October 22, 2
2013-10-22
Monoclonal antibodies against stromal derived factor-1 (SDF-1)
Grant 8,496,931 - Pogue , et al. July 30, 2
2013-07-30
Human CTLA-4 Antibodies And Their Uses
App 20130136749 - Korman; Alan J. ;   et al.
2013-05-30
Human monoclonal antibodies that bind CXCR4
Grant 8,450,464 - Kuhne , et al. May 28, 2
2013-05-28
Human Monoclonal Antibodies To Programmed Death 1 (PD-1) And Methods For Treating Cancer Using Anti-PD-1 Antibodies Alone Or In Combination With Other Immunotherapeutics
App 20130133091 - Korman; Alan J. ;   et al.
2013-05-23
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1)
App 20130122014 - Korman; Alan J. ;   et al.
2013-05-16
Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)
Grant 8,383,796 - Korman , et al. February 26, 2
2013-02-26
Pd-1 Antibodies In Combination With A Cytokine-secreting Cell And Methods Of Use Thereof
App 20130022600 - LI; Betty ;   et al.
2013-01-24
Human CTLA-4 antibodies and their uses
Grant 8,318,916 - Korman , et al. November 27, 2
2012-11-27
PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
Grant 8,287,856 - Li , et al. October 16, 2
2012-10-16
Fully Human Antibodies To Btla
App 20120183565 - Mataraza; Jennifer Marie ;   et al.
2012-07-19
Methods of treatment using CTLA-4 antibodies
Grant 8,142,778 - Davis , et al. March 27, 2
2012-03-27
Human CTLA-4 Antibodies And Their Uses
App 20110296546 - Korman; Alan J. ;   et al.
2011-12-01
Human CTLA-4 antibodies and their uses
Grant 8,017,114 - Korman , et al. September 13, 2
2011-09-13
Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
Grant 8,008,449 - Korman , et al. August 30, 2
2011-08-30
Human Monoclonal Antibodies To Programmed Death Ligand 1 (PD-L1)
App 20110209230 - Korman; Alan J. ;   et al.
2011-08-25
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3) And Uses Thereof
App 20110150892 - Thudium; Kent B. ;   et al.
2011-06-23
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
Grant 7,943,743 - Korman , et al. May 17, 2
2011-05-17
Pd-1 Antibodies In Combination With A Cytokine-secreting Cell And Methods Of Use Thereof
App 20100285013 - Li; Betty ;   et al.
2010-11-11
Monoclonal Antibodies Against Stromal Derived Factor-1 (sdf-1)
App 20100158902 - Pogue; Sarah L. ;   et al.
2010-06-24
Human CTLA-4 Antibodies and Their Uses
App 20100047244 - Korman; Alan J. ;   et al.
2010-02-25
Human CTLA-4 antibodies and their uses
Grant 7,605,238 - Korman , et al. October 20, 2
2009-10-20
Human Monoclonal Antibodies To Programmed Death 1(PD-1) And Methods For Treating Cancer Using Anti-PD-1 Antibodies Alone or in Combination with Other Immunotherapeutics
App 20090217401 - Korman; Alan J. ;   et al.
2009-08-27
Methods Of Treatment Using CTLA-4 Antibodies
App 20090117037 - Davis; Thomas Andrew ;   et al.
2009-05-07
Human Monoclonal Antibodies To O8E
App 20090074660 - Korman; Alan J. ;   et al.
2009-03-19
Human Monoclonal Antibodies To Be Programmed Death Ligand 1 (pd-l1)
App 20090055944 - Korman; Alan J. ;   et al.
2009-02-26
Pd-1 Antibodies In Combination With A Cytokine-secreting Cell And Methods Of Use Thereof
App 20090028857 - Li; Betty ;   et al.
2009-01-29
Methods of treatment using CTLA-4 antibodies
Grant 7,452,535 - Davis , et al. November 18, 2
2008-11-18
Human CTLA-4 antibodies
Grant 6,984,720 - Korman , et al. January 10, 2
2006-01-10
Human CTLA-4 antibodies and their uses
App 20050201994 - Korman, Alan J. ;   et al.
2005-09-15
Methods of treatment using CTLA-4 antibodies
App 20040005318 - Davis, Thomas Andrew ;   et al.
2004-01-08
Human CTLA-4 antibodies and their uses
App 20020086014 - Korman, Alan J. ;   et al.
2002-07-04
Nucleic acid ligands to CD40ligand
Grant 6,171,795 - Korman , et al. January 9, 2
2001-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed